Journey Medical

DERM66

High Growth

$5.37arrow_drop_up2.78%$0.14

High Growth

DERM66

$5.37

arrow_drop_up2.78%$0.14

High Growth

Performance History

Key Stats
Open	$5.17
Prev. Close	$5.20
EPS	-0.92
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-
Market Cap	$112.17M
PE Ratio	-

	LOW	HIGH
Day Range	4.94	5.61
52 Week Range	2.65	8.11

Ratios







EPS	-0.92

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Journey Medical (DERM)

Dermira Inc (DERM) is a pharmaceutical company that specializes in developing and commercializing innovative therapies for dermatologic conditions. The company's stock price history has shown some volatility over the years, with fluctuations in response to news and market trends. Investors can track the performance of Dermira Inc by monitoring the stock price and analyzing trends. The stock quote for Dermira Inc provides up-to-date information on the current trading price of the company's shares. This allows investors to make informed decisions based on the market value of the stock.

In addition to stock price updates, it is crucial to stay updated with the latest news about Dermira Inc. News articles provide insights into the company's developments, such as clinical trials, FDA approvals, partnerships, and other key events that can impact its stock performance. By staying informed about Dermira Inc's news, investors can gauge the potential impact on the company's future prospects. Analyzing the stock is another essential aspect of investment decision-making. Investors can evaluate the company's financial performance, growth potential, and competitive position by conducting a thorough stock analysis.

Websitecall_made

Sector: Healthcare
Industry: Drug Manufacturers—Specialty & Generic
CEO: Mr. Claude Maraoui
Headquarters: Scottsdale
Employees: 20
Exchange: NASDAQ

Keep an eye on Journey Medical

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Journey Medical's (DERM) price per share?

The current price per share for Journey Medical (DERM) is $5.37. The stock has seen a price change of $0.14 recently, indicating a 2.79% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Journey Medical (DERM)?

For Journey Medical (DERM), the 52-week high is $8.11, which is 51.02% from the current price. The 52-week low is $2.65, the current price is 102.64% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Journey Medical (DERM) a growth stock?

Journey Medical (DERM) has shown an average price growth of -3.66% over the past three years. It has received a score of 82 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Journey Medical as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Journey Medical (DERM) stock price performance year to date (YTD)?

As of the latest data, Journey Medical (DERM) has a year-to-date price change of -1.1%. Over the past month, the stock has experienced a price change of -0.92%. Over the last three months, the change has been 10.49%. Over the past six months, the figure is 49.17%. Looking at a longer horizon, the five-year price change stands at -38.98%.

help

Is Journey Medical (DERM) a profitable company?

Journey Medical (DERM) has a net income of -$3.85M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 66.33% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -19.78% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $79.18M, with a revenue growth rate of 7.48%, providing insight into the company's sales performance and growth. The gross profit is $52.52M. Operating income is noted at -$2.07M. Furthermore, the EBITDA is $5.25M.

help

What is the market capitalization of Journey Medical (DERM)?

Journey Medical (DERM) has a market capitalization of $112.18M. The average daily trading volume is 5.48, indicating the stock's liquidity and investor engagement.

News

JOURNEY MEDICAL CORPORATION

EMROSI

ROSACEA

FDA APPROVAL

PHASE 3 CLINICAL TRIALS

Nov 4, 2024

Journey Medical Corporation Announces U.S. FDA Approval of Emrosi™ (Minocycline Hydrochloride Extended Release Capsules, 40 mg) for the Treatment of Rosacea

CALENDAR OF EVENTS

May 15, 2024

Journey Medical Corporation to Participate in the Alliance Global Partners’ (A.G.P.) Virtual Healthcare Company Showcase

EARNINGS RELEASES AND OPERATING RESULTS

May 13, 2024

Journey Medical Corporation Reports First Quarter 2024 Financial Results and Recent Corporate Highlights

CONFERENCE CALLS/ WEBCASTS

May 7, 2024

Journey Medical Corporation to Announce First Quarter 2024 Financial Results on May 13, 2024

DIRECTORS AND OFFICERS

May 1, 2024

Journey Medical Corporation Appoints Joseph Benesch as Chief Financial Officer